Dong-A Socio Holdings Co., Ltd. announces an Equity Buyback for 140,000 shares.
March 20, 2020 at 02:45 am EDT
Share
Dong-a Pharmaceutical Co. Ltd. (KOSE:A000640) announces a share repurchase program. Under the program, the company will repurchase up to 140,000 shares. The purpose of the program is to enhance shareholder value through stable stock prices. The program will expire on June 22, 2020. As of March 19, 2020, the company has no shares directly owned and no shares under contract in treasury stock.
Dong-A Socio Holdings Co Ltd is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through five segments. The Medicine Manufacturing segment is engaged in the manufacture and sale of pharmaceuticals. The main pharmaceuticals include tonic medicines, cold medicines, raw material medicines. The Logistic segment is involved in the freight, courier, car transportation, freight warehousing and leasing business. The Packaging segment is engaged in manufacturing and sale of glass and glass products. The Holding Company segment is engaged in the provision of core companies and management consulting services. The Other segment is engaged in the production and sale of information and communication technology (IT) solutions and agricultural products, as well as real estate development business.
DONG-A SOCIO HOLDINGS CO., LTD. 
